2012, Number 2
<< Back Next >>
Rev Cub Oftal 2012; 25 (2)
Changes in the cell structure of patients with keratoconus under cross-linking treatment by using confocal microscopy
Jareño OM, Pérez PZ, Fernández GK, Castillo PAC, Escalona LE, Ruiz RY
Language: Spanish
References: 19
Page:
PDF size: 322.31 Kb.
ABSTRACT
Objective: to describe the changes of the corneal cellular structure of patients with keratoconus after the cross-linking treatment.
Methods: the sample was made up of 30 eyes from 30 patients, who had progressive keratoconus and were treated with corneal collagen crosslinking and confocal microscopy. The analyzed variables were the alterations in the sub-basal and sub-epithelial nervous plexuses, in the stromal nerves, the changes in keratocytes in the anterior and medium stroma, the changes of the endothelial cells, the depth of treatment as well as the presence and the progression of haze and the stromal edema.
Results: there no sub-basal and sub-epithelial nervous plexuses during the first month, there were re-innervations after 6 months in 73,3 % of eyes and total recovery after 12 months. Likewise, there was no stromal nervous fibers in the first month, but after 6 months they were recovered in 96,7 % of patients and the total recovery was attained after a year. Rarefaction of the keratocytes in the anterior and the medium stroma was found during the first month in 96,7 % of cases, the onset of the cell repopulation was observed after 3 months in 83,3 % of cases and a total regeneration was evident after 1 year. The stromal edema was present in the first month in 83,3 % of cases, 6 months later was seen in 3.3 % and after 1 year, no patient was affected. Haze was identified on the first month and after 3 months in 100 % of patients. The haze grade II predominated in the first month, the grade I after 6 months and 60 % of patients presented with no haze after a year.
Conclusions: the obtained results confirmed the criteria which establish that the corneal collagen crosslinking is a safe treatment method.
REFERENCES
Patel DV, McGhee NJ. Mapping the corneal sub-basal nerve plexus in Keratoconus by in vivo Laser scanning confocal microscopy. Invest of Ophthalmol Vis Sci. 2006;47(4):1348-51.
Niederer RL, Perumal D, Sherwin T, McGhee NJ. Laser Scanning in vivo Confocal Microscopy reveals reduced innervation and reduction in cell density in all layers of the Keratoconic cornea. Invest Ophthalmol Vis Sci. 2008;49(7):2964-70.
Torres RM, Merayo-Lloves J, Jaramillo MA, Galvis V. Biomecánica de la córnea. Arch Soc Esp Oftalmol. [citado: 18 enero 2012] 2005;80(4). Disponible en: http://scielo.isciii.es/scielo.php?pid=S036566912005000400004&script=sci_arttext
Wollensak G, Aurich H, Wirbelauer C, Sel S. Significance of the riboflavin film in corneal collagen crosslinking. J Cataract Refract Surg. 2010;36(1):114-20.
Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA. Cornea. 2004;23(5):503-7.
Mastropasgua L, Nubile M. Normal Corneal Morphology: En: Mastropasgua L, Nubile M. Confocal Microscopy of the cornea. Hertfordshire: SLACK; 2002. p. 7-16.
Wollensak GE, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620-7.
Tavakoli M, Hossain P, Malik RA. Clinical applications of corneal confocal microscopy. Clinical Ophthalmology. 2008;2(2):435-45.
Oliveira Soto O, Efron N. Morphology of corneal nerves using confocal microscopy. Cornea. 2001;20(4):374-84.
Lee JS, Oum BS, Choi HY, Lee JE, Cho BM. Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye. 2006;20(3):315-8.
Mazzotta C, Traversi C, Baiocchi S, Caporossi O, Bovone C, Sparano MC, et al. Corneal healing after riboflavin ultraviolet-A collagen cross-linking determined by confocal laser scanning microscopy in vivo: early and late modifications. Am J Ophthalmol. 2008;146(4):527-33.
Mazzotta C, Traversi C, Baiocchi S, Sergio P, Caporossi T, Caporossi A. Conservative treatment of keratoconus by riboflavin-UV-A-induced cross-linking of corneal collagen: qualitative investigation. Eur J Ophthalmol. 2006;16(4):530-5.
Mazzotta C, Balestrazzi A, Traversi C, Baiocchi S, Caporossi T, Tommasi C, et al. Treatment of progressive keratoconus by riboflavin-UV-A-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans. Cornea. 2007;26(4):390-7.
Kymionis G, Diakonis VF, Kalyvianaki M, Portaliou D, Siganos Ch, Kozobolis VP, et al. Year Follow-up of Corneal Confocal Microscopy after Corneal Cross-Linking in Patients with Post Laser in Situ Keratosmileusis Ectasia and Keratoconus. Am J Ophthalmol. 2009;147(5):774-9.
Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T. Parasurgical therapy for keratoconus by riboflavinultraviolet type a rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg. 2006;32(5):837-45.
Wollensak G, Spoerl E, Wilsch M, Seiler T. Keratocyte apoptosis after corneal collagen crosslinking using riboflavin/UVA treatment. Cornea. 2004;23(1):43-9.
Tomkins O, Garzozi HJ. Collagen cross-linking: Strengthening the unstable cornea. Clinical Ophthalmology. 2008;2(4):863-7.
Raiskup FD, Hoyer A, Spoerl E. Permanent Corneal Haze after Riboflavin-UVA-induced Cross-linking in Keratoconus. Journal of Refractive Surgery. 2009;25(9):824-8.
Kymionis GD, Portaliou DM, Pallikaris IG. Additional complications of corneal crosslinking. J Cataract Refract Surg. 2010;36(1):185.